Roche

CINtec PLUS is an innovative brand that specializes in advanced diagnostics for cervical cancer screening. Their flagship product, the CINtec PLUS Cytology Kit, is an immunocytochemistry assay designed for the dual detection of p16INK4a and Ki-67 proteins in cervical cytology preparations. This cutting-edge test assists healthcare professionals in identifying women at risk for high-grade cervical intraepithelial lesions, particularly in those with atypical Pap results or high-risk HPV positives.

The CINtec PLUS Cytology Kit employs dual-biomarker technology, enabling accurate and simultaneous assessment, which enhances screening efficacy and minimizes misdiagnosis. It provides immediate actionable results, empowering clinicians to recommend appropriate follow-up procedures, such as colposcopy, for patients who need additional evaluation. As a CE-IVD certified product intended for in vitro diagnostic use, CINtec PLUS exemplifies Roche Diagnostics' commitment to improving women's health management through enhanced screening approaches and innovative diagnostic solutions. This helps ensure that women receive the care and attention necessary for timely intervention and better health outcomes.